abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
R&D Expense Growth
0.00%
Fiscal year · Period ending:
HQL R&D Expense Growth
Latest reported0.00%period ending
Latest reported0.00%period ending
HQL FY R&D Growth (YoY) (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
HQL r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| 0% | |
| 100% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| -100% | |
| 177.061% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |